Renal papillary necrosis is a condition in which the renal papillae, the small projections on the surface of the kidney, become damaged or die. It is a serious condition that can lead to kidney failure if left untreated. The exact cause of renal papillary necrosis is unknown, but there are some risk factors that can increase a person’s chances of developing the condition. In addition, there are treatments available to help manage the symptoms and slow the progression of the condition. This article will explore the causes and treatment of renal papillary necrosis.
Renal papillary necrosis is a condition in which the renal papillae, the small projections on the surface of the kidney, become damaged or die. The condition can be caused by a number of factors, including dehydration, infection, or certain medications. It is most common in people with diabetes, kidney disease, or those who have recently undergone a kidney transplant. The condition is usually diagnosed with an imaging test such as an ultrasound or CT scan. Symptoms of renal papillary necrosis include pain in the side or lower back, fever, chills, nausea, and vomiting. If left untreated, the condition can lead to kidney failure.
The exact cause of renal papillary necrosis is unknown, but there are some risk factors that can increase a person’s chances of developing the condition. These include: - Diabetes: People with diabetes are more likely to develop renal papillary necrosis because of their increased risk of dehydration and infection. - Kidney Disease: People with existing kidney disease are more likely to develop renal papillary necrosis due to their weakened immune system. - Medications: Certain medications, such as non-steroidal anti-inflammatory drugs (NSAIDs), can increase the risk of developing renal papillary necrosis. - Dehydration: Dehydration can increase the risk of developing renal papillary necrosis. - Infection: Infections, such as urinary tract infections, can increase the risk of developing renal papillary necrosis.
Treatment for renal papillary necrosis depends on the underlying cause of the condition. If the condition is caused by dehydration, the patient may be given fluids to rehydrate them. If the condition is caused by an infection, antibiotics may be prescribed. If the condition is caused by certain medications, the doctor may recommend alternative medications. In some cases, surgery may be necessary to remove the damaged renal papillae. This is usually done if the condition is causing pain or other symptoms. In addition, medications such as diuretics may be prescribed to help reduce the swelling in the kidneys.
There are some steps that can be taken to reduce the risk of developing renal papillary necrosis. These include: - Drinking plenty of fluids: Drinking plenty of fluids can help prevent dehydration, which can increase the risk of developing renal papillary necrosis. - Avoiding certain medications: Avoiding certain medications, such as NSAIDs, can reduce the risk of developing renal papillary necrosis. - Managing diabetes: People with diabetes should take steps to manage their condition to reduce their risk of developing renal papillary necrosis. - Maintaining a healthy lifestyle: Eating a healthy diet and exercising regularly can help reduce the risk of developing renal papillary necrosis.
Renal papillary necrosis is a serious condition that can lead to kidney failure if left untreated. The exact cause of the condition is unknown, but there are some risk factors that can increase a person’s chances of developing it. Treatment for the condition depends on the underlying cause, but can include fluids, antibiotics, and surgery. In addition, there are steps that can be taken to reduce the risk of developing renal papillary necrosis, such as drinking plenty of fluids, avoiding certain medications, managing diabetes, and maintaining a healthy lifestyle.
1.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
2.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
3.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
4.
Month-Long Wait Times Caused by US Physician Shortage.
5.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
1.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
2.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
3.
Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice
4.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
5.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation